Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Cash Flow Quality Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Cash Flow Quality Index of 0.33x as of December 2023. Operating cash flow of CN¥90.45 Million is below net income of CN¥271.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hangzhou Bio-Sincerity Pharma-Tech Co.Lt cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hangzhou Bio-Sincerity Pharma-Tech Co.Lt (301096) cash flow conversion.
Annual Cash Flow Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Year-by-year earnings quality comparison for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.33x | CN¥90.45 Million | CN¥271.97 Million | ▼ -75.1% |
| 2022 | 1.34x | CN¥259.41 Million | CN¥194.16 Million | ▲ +2.0% |
| 2021 | 1.31x | CN¥145.42 Million | CN¥110.97 Million | ▲ +38.4% |
| 2020 | 0.95x | CN¥54.36 Million | CN¥57.40 Million | ▼ -41.2% |
| 2019 | 1.61x | CN¥71.47 Million | CN¥44.40 Million | — |